Reporting on acquisition of treasury shares
Regulated information
Aalst, Belgium, April 11, 2025 – In accordance with article 8:4 of the Royal Decree of April 2, 2019 executing the Belgian Code of Companies and Associations, Ontex hereby discloses information in relation to its program to buy back treasury shares, which was announced on November 25, 2024.
During the work week ending on April 11, 2025, Ontex repurchased 118,758 shares on the regulated market of Euronext Brussels, as set out in the table below.
| Date | # shares | Average price (in €) | Minimum price (in €) | Maximum price (in €) | Total value (in €) |
| 07/04/2025 | 28,001 | 7.708 | 7.650 | 7.790 | 215,828 |
| 08/04/2025 | 18,000 | 7.897 | 7.880 | 7.910 | 142,140 |
| 09/04/2025 | 38,500 | 7.501 | 7.450 | 7.550 | 288,785 |
| 10/04/2025 | 34,257 | 7.754 | 7.720 | 7.790 | 265,646 |
On December 2, 2024, Ontex launched a share buy-back program to acquire a maximum of 1.5 million shares. On April 10, 2025, the program was finalized with all 1.5 million shares repurchased. The shares acquired will contribute to meeting Ontex’s obligations under its current and future long-term incentive plans. The program is conducted under the terms and conditions of the authorization granted by the extraordinary shareholders’ meeting held on May 5, 2023, and is executed by an independent intermediary, who will make its decisions independently pursuant to a discretionary mandate.
Enquiries
- Investors Geoffroy Raskin +32 53 33 37 30 [email protected]
- Media Catherine Weyne +32 53 33 36 22 [email protected]
About Ontex
Ontex is a leading international developer and producer of baby, feminine and adult care products, both for retailers and the healthcare sector. Ontex’s innovative products are distributed in around 100 countries through retailers and healthcare providers. Employing some 7,000 people, Ontex has a presence in 14 countries, with its headquarters in Aalst, Belgium. Ontex is listed on Euronext Brussel and is a constituent of the Bel Mid® index. To keep up with the latest news, visit ontex.com or follow Ontex on LinkedIn.
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
- BNB Price Prediction: $1,000 BNB Calls Return as AlphaPepe Targets Token-Safety Intelligence
- GAC Group to Celebrate 30 Million Global Users on July 16
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share